Emerging Vaccine-Breakthrough SARS-CoV-2 Variants
- 8 February 2022
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 8 (3) , 546-556
Abstract
No abstract availableKeywords
Funding Information
- Division of Mathematical Sciences (DMS-1761320, DMS-2052983)
- Pfizer
- Bristol-Myers Squibb (65109)
- Michigan Economic Development Corporation
- National Aeronautics and Space Administration (80NSSC21M0023)
- Michigan State University Research Foundation
- National Institute of General Medical Sciences (GM126189)
- Division of Information and Intelligent Systems (IIS-1900473)
This publication has 47 references indexed in Scilit:
- Identification of Two Critical Amino Acid Residues of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Its Variation in Zoonotic Tropism Transition via a Double Substitution StrategyJournal of Biological Chemistry, 2021
- Structural and physico-chemical effects of disease and non-disease nsSNPs on proteinsCurrent Opinion in Structural Biology, 2015
- Insights into RNA synthesis, capping, and proofreading mechanisms of SARS-coronavirusVirus Research, 2014
- Persistent homology analysis of protein structure, flexibility, and foldingInternational Journal for Numerical Methods in Biomedical Engineering, 2014
- Topology and dataBulletin of the American Mathematical Society, 2009
- SNP Genotyping: Technologies and Biomedical ApplicationsAnnual Review of Biomedical Engineering, 2007
- Bats Are Natural Reservoirs of SARS-Like CoronavirusesScience, 2005
- Loss of Protein Structure Stability as a Major Causative Factor in Monogenic DiseaseJournal of Molecular Biology, 2005
- Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and humanProceedings of the National Academy of Sciences, 2005
- Interpreting enzyme and receptor kinetics: keeping it simple, but not too simpleNuclear Medicine and Biology, 2003